u.s..-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018..
friday, may 18, 2018 .
“it may be just out of an abundance of caution and privacy. certainly, staying a little longer may imply that this is a little bit more of a complex situation.”.
. (open access) shows that athletes of the mind � chess grandmasters � show the same longevity advantage as athletes of the body..